Clinical Trial Update: Therapeutic Response of Cannabidiol in Rheumatoid Arthritis [Phase 1]

View source ↗

Summary

Phase 1 clinical trial evaluating the safety and preliminary therapeutic response of cannabidiol in patients with rheumatoid arthritis; study completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Rheumatoid Arthritis

Drugs mentioned

• Cannabidiol (cannabidiol)

Snippet

Sponsor: University of California, Los Angeles | Conditions: Rheumatoid Arthritis, Cannabis | Phase 1 | Status: COMPLETED